Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT02017405 · ClinicalTrials.gov registry record · NA

Study Evaluating the Digestibility of Serum-Derived Bovine Immunoglobulin Protein Isolate in Healthy Adults

A NA study of Healthy, sponsored by Entera Health.

Completed
Registry status
NA
Development phase
42
Enrollment target
2
Study locations

NCT02017405 is a NA study of Healthy that has completed, run by Entera Health. The registered enrollment target is 42 participants, below the 647-participant average among 1,090 other Healthy trials with a reported enrollment target (94% lower). The trial reports 2 study locations across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT02017405, a NA study of Healthy, has completed, sponsored by Entera Health.

COMPLETED
Registry status
NA
Development phase
42 participants
Enrollment target
2
Study locations

Study Summary

The purpose of this study is to determine the digestibility of serum-derived bovine immunoglobulin protein isolate in healthy adults. The information generated may help elucidate SBI's mechanism of action.

Conditions Studied

Interventions

  • OTHER Matching Placebo
  • OTHER Serum-derived bovine immunoglobulin protein isolate (SBI)

Study Locations (2)

North Carolina

  • PMG Research of Cary - Cary
  • Wake Research Associates - Raleigh

Trial Details

FieldValue
Enrollment Target 42 participants
Start Date 2013-12
Est. Completion 2014-11
Phase NA

Sponsor

Entera Health

4 total trials

What the Registry Record Tells You About NCT02017405

The ClinicalTrials.gov registry entry for NCT02017405 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 42 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 647-participant average among 1,090 other Healthy trials with a reported enrollment target (94% lower). The listed sponsor is Entera Health, which has 4 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with Healthy appearing as the primary indexed condition, and to 2 interventions - of which Matching Placebo is the first listed.

NCT02017405 reports 2 study locations spanning 1 distinct geographic area - top geographies include North Carolina.

Frequently Asked Questions

What is clinical trial NCT02017405 about?

NCT02017405 is a clinical study titled "Study Evaluating the Digestibility of Serum-Derived Bovine Immunoglobulin Protein Isolate in Healthy Adults". The purpose of this study is to determine the digestibility of serum-derived bovine immunoglobulin protein isolate in healthy adults. The information generated may help elucidate SBI's mechanism of action.

What is the current status of trial NCT02017405?

This trial is currently completed. It is a NA study. The enrollment target is 42 participants. The study started on 2013-12. Estimated completion is 2014-11.

What conditions does trial NCT02017405 study?

This clinical trial studies the following conditions: Healthy.

What interventions are being tested in trial NCT02017405?

The interventions under investigation include: Matching Placebo (OTHER), Serum-derived bovine immunoglobulin protein isolate (SBI) (OTHER).

Who is sponsoring clinical trial NCT02017405?

This trial is sponsored by Entera Health, which has 4 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT02017405 being conducted?

This trial has 2 study locations across North Carolina. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Healthy

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.